Lobbying client
EPIOMED THERAPEUTICS
drug discovery and development organization with a therapeutic focus
Filings
22
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2012 to 2018
Filings
22 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination Amendment (No Activity) 4th Quarter 2018
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2017
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
1st Quarter - Report 1st Quarter 2017
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2016
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2016
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
1st Quarter - Termination (No Activity) 1st Quarter 2016
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2015
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2015
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
1st Quarter - Amendment (No Activity) 1st Quarter 2015
|
AEROSPACE INTELLIGENCE, LLC | — reported |
|
2nd Quarter - Amendment (No Activity) 2nd Quarter 2015
|
AEROSPACE INTELLIGENCE, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| AEROSPACE INTELLIGENCE, LLC | 20 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.